Dingyi Lv

619 total citations
29 papers, 461 citations indexed

About

Dingyi Lv is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Immunology. According to data from OpenAlex, Dingyi Lv has authored 29 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 8 papers in Cardiology and Cardiovascular Medicine and 6 papers in Immunology. Recurrent topics in Dingyi Lv's work include Inflammasome and immune disorders (9 papers), Lipid metabolism and disorders (4 papers) and interferon and immune responses (3 papers). Dingyi Lv is often cited by papers focused on Inflammasome and immune disorders (9 papers), Lipid metabolism and disorders (4 papers) and interferon and immune responses (3 papers). Dingyi Lv collaborates with scholars based in China and United States. Dingyi Lv's co-authors include Minghao Luo, Suxin Luo, Jianghong Yan, Fei‐Fei Shang, Yongzheng Guo, Zhe Cheng, Ruiyu Wang, Ke Liao, Jian Shen and Yu Hu and has published in prestigious journals such as Advanced Functional Materials, Biochemical and Biophysical Research Communications and Journal of Ethnopharmacology.

In The Last Decade

Dingyi Lv

28 papers receiving 458 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dingyi Lv China 16 263 104 80 59 48 29 461
Jiamei Lu China 13 264 1.0× 89 0.9× 34 0.4× 88 1.5× 68 1.4× 24 542
Ignacio Norambuena‐Soto Chile 11 247 0.9× 55 0.5× 82 1.0× 98 1.7× 69 1.4× 20 504
Harsha Nagar South Korea 14 215 0.8× 61 0.6× 39 0.5× 78 1.3× 84 1.8× 31 441
Dingping Yang China 17 196 0.7× 72 0.7× 31 0.4× 88 1.5× 45 0.9× 29 538
Xiaowen Wang China 16 223 0.8× 43 0.4× 103 1.3× 97 1.6× 70 1.5× 37 566
Wenjuan Liu China 11 215 0.8× 39 0.4× 148 1.9× 38 0.6× 30 0.6× 21 389
Biao Xu China 11 201 0.8× 35 0.3× 106 1.3× 47 0.8× 75 1.6× 17 445
Yongzheng Guo China 16 273 1.0× 78 0.8× 138 1.7× 70 1.2× 156 3.3× 34 559
Chuanshi Xiao China 11 166 0.6× 38 0.4× 77 1.0× 96 1.6× 63 1.3× 24 390

Countries citing papers authored by Dingyi Lv

Since Specialization
Citations

This map shows the geographic impact of Dingyi Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dingyi Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dingyi Lv more than expected).

Fields of papers citing papers by Dingyi Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dingyi Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dingyi Lv. The network helps show where Dingyi Lv may publish in the future.

Co-authorship network of co-authors of Dingyi Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Dingyi Lv. A scholar is included among the top collaborators of Dingyi Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dingyi Lv. Dingyi Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pan, Lina, Haiyan Chen, Liyuan Chen, et al.. (2025). Bifunctional Peptide‐Engineered Mitochondria Alleviate Myocarditis and Cardiac Fibrosis by Site‐Specifically Inhibiting NETosis. Advanced Functional Materials. 35(49).
2.
Zhao, Guozhi, Cheng Zhang, Minghao Luo, et al.. (2025). Hypoglycemia Induces Diabetic Macrovascular Endothelial Dysfunction via Endothelial Cell PANoptosis, Macrophage Polarization, and VSMC Fibrosis. Advanced Science. 12(37). e14530–e14530. 1 indexed citations
3.
Xue, Yuzhou, Yu Hu, Lin Liu, et al.. (2024). The lncRNA GAS5 upregulates ANXA2 to mediate the macrophage inflammatory response during atherosclerosis development. Heliyon. 10(2). e24103–e24103. 4 indexed citations
4.
Hu, Yu, et al.. (2024). LncRNA Pvt1 aggravates cardiomyocyte apoptosis via the microRNA-216/Ccnd3 axis. Heliyon. 10(19). e38261–e38261. 2 indexed citations
5.
Luo, Minghao, et al.. (2024). Dapagliflozin ameliorates myocardial infarction injury through AMPKα-dependent regulation of oxidative stress and apoptosis. Heliyon. 10(7). e29160–e29160. 6 indexed citations
6.
7.
8.
You, Yuehua, Fei‐Fei Shang, Xiaowen Wang, et al.. (2023). iNOS aggravates pressure overload-induced cardiac dysfunction via activation of the cytosolic-mtDNA-mediated cGAS-STING pathway. Theranostics. 13(12). 4229–4246. 26 indexed citations
9.
Luo, Minghao, Dingyi Lv, Yuzhou Xue, et al.. (2023). LncRNA GAS5 downregulates NLRP3 inflammasome activation-mediated pyroptosis in sepsis-induced myocardial injury by targeting SIRT3/AMPKα. Heliyon. 9(12). e22939–e22939. 6 indexed citations
10.
11.
Luo, Minghao, Yu Hu, Dingyi Lv, et al.. (2022). Recurrent Hypoglycemia Impaired Vascular Function in Advanced T2DM Rats by Inducing Pyroptosis. Oxidative Medicine and Cellular Longevity. 2022(1). 7812407–7812407. 11 indexed citations
12.
He, An, Yu Hu, Xiang Li, et al.. (2022). Honokiol improves endothelial function in type 2 diabetic rats via alleviating oxidative stress and insulin resistance. Biochemical and Biophysical Research Communications. 600. 109–116. 11 indexed citations
13.
Liao, Ke, Yu Hu, Dingyi Lv, et al.. (2022). Role of the cGAS-STING Pathway in Aging-related Endothelial Dysfunction. Aging and Disease. 13(6). 1901–1901. 45 indexed citations
14.
Liu, Qian, et al.. (2022). SIRT3-AMPK signaling pathway as a protective target in endothelial dysfunction of early sepsis. International Immunopharmacology. 106. 108600–108600. 29 indexed citations
15.
Zhang, Ziyue, Minghao Luo, Zhe Cheng, et al.. (2022). NLRP3 inflammasome contributes to endothelial dysfunction in angiotensin II-induced hypertension in mice. Microvascular Research. 143. 104384–104384. 22 indexed citations
16.
Lv, Dingyi, et al.. (2022). Trophoblastic mitochondrial DNA induces endothelial dysfunction and NLRP3 inflammasome activation: Implications for preeclampsia. International Immunopharmacology. 114. 109523–109523. 13 indexed citations
17.
18.
Lv, Dingyi, Minghao Luo, Zhe Cheng, et al.. (2021). Tubeimoside I Ameliorates Myocardial Ischemia‐Reperfusion Injury through SIRT3‐Dependent Regulation of Oxidative Stress and Apoptosis. Oxidative Medicine and Cellular Longevity. 2021(1). 5577019–5577019. 24 indexed citations
19.
Luo, Minghao, Suxin Luo, Zhe Cheng, et al.. (2020). Tubeimoside I improves survival of mice in sepsis by inhibiting inducible nitric oxide synthase expression. Biomedicine & Pharmacotherapy. 126. 110083–110083. 20 indexed citations
20.
Guo, Yongzheng, Yuehua You, Dingyi Lv, et al.. (2019). Inducible nitric oxide synthase contributes to insulin resistance and cardiac dysfunction after burn injury in mice. Life Sciences. 239. 116912–116912. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiamei Lu Breakdown of academic impact, for papers by Ignacio Norambuena‐Soto Breakdown of academic impact, for papers by Harsha Nagar Breakdown of academic impact, for papers by Dingping Yang Breakdown of academic impact, for papers by Xiaowen Wang Breakdown of academic impact, for papers by Wenjuan Liu Breakdown of academic impact, for papers by Biao Xu Breakdown of academic impact, for papers by Yongzheng Guo Breakdown of academic impact, for papers by Chuanshi Xiao
Rankless by CCL
2026